Expertise of European Clinical Trial Units in Conducting and Managing Cross-Border Pediatric Clinical Trials for Rare Diseases

Begonya Nafria, Segolene Gaillard, Martine Dehlinger-Kremer, Pamela Dicks, Ricardo M. Fernandes, Pirkko Lepola, Gunter F. Egger, Lucy Bray, Barbara E. Bierer, Bob Phillips

Open source

DOI
10.1007/s43441-026-00997-x
Published
2026-06-18
Container
Therapeutic Innovation & Regulatory Science
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s43441-026-00997-x,
  title = {Expertise of European Clinical Trial Units in Conducting and Managing Cross-Border Pediatric Clinical Trials for Rare Diseases},
  author = {Begonya Nafria and Segolene Gaillard and Martine Dehlinger-Kremer and Pamela Dicks and Ricardo M. Fernandes and Pirkko Lepola and Gunter F. Egger and Lucy Bray and Barbara E. Bierer and Bob Phillips},
  year = {2026},
  journal = {Therapeutic Innovation \& Regulatory Science},
  doi = {10.1007/s43441-026-00997-x},
  url = {https://doi.org/10.1007/s43441-026-00997-x}
}

RIS

TY  - JOUR
TI  - Expertise of European Clinical Trial Units in Conducting and Managing Cross-Border Pediatric Clinical Trials for Rare Diseases
AU  - Begonya Nafria
AU  - Segolene Gaillard
AU  - Martine Dehlinger-Kremer
AU  - Pamela Dicks
AU  - Ricardo M. Fernandes
AU  - Pirkko Lepola
AU  - Gunter F. Egger
AU  - Lucy Bray
AU  - Barbara E. Bierer
AU  - Bob Phillips
PY  - 2026
JO  - Therapeutic Innovation & Regulatory Science
DO  - 10.1007/s43441-026-00997-x
UR  - https://doi.org/10.1007/s43441-026-00997-x
ER  - 

APA

Nafria, B., Gaillard, S., Dehlinger-Kremer, M., Dicks, P., Fernandes, R. M., Lepola, P., Egger, G. F., Bray, L., Bierer, B. E., & Phillips, B. (2026). Expertise of European Clinical Trial Units in Conducting and Managing Cross-Border Pediatric Clinical Trials for Rare Diseases. Therapeutic Innovation & Regulatory Science. https://doi.org/10.1007/s43441-026-00997-x

Source records